5 February 2026 -- Sheffield, UK -- SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters.

4 February 2026 -- Komaki, Japan -- santec Holdings Corporation is pleased to announce the establishment of a new European service centre.

3 February 2026 -- Colorado, US -- Cirena, pioneers in long and ultra-long, high purity RNA synthesis for gene editing and functional genomics, today announced its public launch following successful delivery of high-quality long RNA to leading academic and pharmaceutical research teams across the U.S., Europe, and Japan.

2 February 2026 -- Zurich, Switzerland -- ABB has introduced its Automation Extended program, a strategic evolution of its distributed control systems (DCS), designed to help industries modernize without disruption.

30 January 2026 -- Indiana, US -- Eli Lilly and Company today announced plans to invest more than $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania.

29 January 2026 -- Paris, France -- Spore.Bio, a company at the intersection of AI, biophotonics, and microbiology, today announced that renowned microbiologist, Dr. Michael J. Miller, has joined as Vice President of Scientific & Regulatory Affairs

27 January 2026 -- Solna, Sweden -- Epigenica AB announces the launch of its EpiFinder Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic research faster, more accessible and highly reproducible.

26 January 2026 -- Stockholm, Sweden -- Recipharm, a leading global contract development and manufacturing organisation (CDMO), has developed a new, dedicated manufacturing facility to meet the latest regulatory expectations for non-bacterial beta-lactam medicines.

22 January 2026 -- New York, US -- In an effort to advance health equity and reach the people that need help most, global digital health innovator Qure.ai has received a grant from the Gates Foundation.

20 January 2026 -- Titisee-Neustadt, Germany -- Testo Saveris, global leader in measurement solutions, has announced the latest software update for its testo Saveris 1 Environmental Monitoring System, designed to address the evolving needs of the pharmaceutical industry by delivering reliable and precise monitoring of key metrics, including temperature and humidity

19 January 2026 -- Sunderland, UK -- Onyx Scientific has announced the expansion of its solid form and material science screening capabilities in 2026, following the celebration of its 25th anniversary at the end of 2025.

15 January 2026 -- Ontario, Canada -- Nicoya Life Sciences, Inc., a leading provider of advanced biophysical characterization tools for biologics discovery and development, today announced the launch of Revo, a label-free binding kinetics platform designed to make gold-standard surface plasmon resonance (SPR) data more accessible to a broader range of researchers.